The trial met its primary endpoint, with patients receiving povetacicept achieving a 52.0% reduction in UPCR at Week 36
Merck emphasized the broader significance of the findings
Primary membranous nephropathy is a chronic autoimmune disease that attacks the kidneys’ filtering units
Vanrafia, a potent endothelin A receptor antagonist, received accelerated approval in the US and China in 2025 for reducing proteinuria in adults with IgAN
If approved, imlifidase has the potential to transform the kidney transplant landscape by enabling highly sensitized patients to also have access to a potentially life-changing kidney transplant
The company operates a chain of mid-sized multi-speciality hospitals
The project focuses on recovering high-quality polycarbonate, a valuable polymer material used in the construction of the filters
Alport Syndrome is caused by genetic mutations affecting type IV collagen in the kidneys, ears, and eyes
Deceased donor kidney transplants are time-critical, and it is uncommon to attempt them robotically
Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody to demonstrate a complete renal response benefit in lupus nephritis in a randomised phase III study
Subscribe To Our Newsletter & Stay Updated
